Cumberland Pharmaceuticals
CPIX
22 hedge funds and large institutions have $2.61M invested in Cumberland Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 3 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 5
0.15% less ownership
Funds ownership: 14.64% → 14.5% (-0.15%)
4% less funds holding
Funds holding: 23 → 22 (-1)
18% less capital invested
Capital invested by funds: $3.18M → $2.61M (-$562K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$13.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$3.88K |
| 3 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
+$346 |
| 4 |
Wells Fargo
San Francisco,
California
|
+$346 |
| 5 |
JP Morgan Chase
New York
|
+$275 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$27.8K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$20K |
| 3 |
Renaissance Technologies
New York
|
-$13.8K |
| 4 |
IC
Innealta Capital
Austin,
Texas
|
-$1.45K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.15K |
CPIX Hedge Fund Activity: Q3 2024 in Review
22 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Cumberland Pharmaceuticals (CPIX) for Q3 2024, worth a combined $2.61M — down 18% from $3.18M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPIX and 2 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 5 added.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $13.8K. The largest seller was Dimensional Fund Advisors, cutting an estimated $27.8K.
- 22 institutional investors held Cumberland Pharmaceuticals (CPIX) as of Q3 2024, down from 23 in Q2 2024.
- Funds reported $2.61M of Cumberland Pharmaceuticals stock for Q3 2024, down 18% quarter-over-quarter.
- 2 funds opened new Cumberland Pharmaceuticals positions in Q3 2024 and 3 closed out, a net change of -1 holder.
- The largest Cumberland Pharmaceuticals buyer in Q3 2024 was Schonfeld Strategic Advisors, an estimated $13.8K added.
- The largest Cumberland Pharmaceuticals seller in Q3 2024 was Dimensional Fund Advisors, an estimated $27.8K sold.
Based on aggregated 13F filings for Q3 2024.